Literature DB >> 19201224

Non-sebaceous lymphadenoma of the parotid gland: immunohistochemical study and DNA ploidy analysis.

Lorena Gallego1, Luis Junquera, Manuel F Fresno.   

Abstract

Nonsebaceous lymphadenoma (NSL) is an unusual benign salivary gland tumor characterized by a predominant lymphoid background, dense lymphoid infiltrate, and absence of sebaceous differentiation. To our knowledge, only 10 previous cases have been reported in the literature. We report an additional case of NSL arising in the parotid gland in 58-year-old female patient. The extensive immunohistochemical investigation of the tumor revealed the presence of both luminal and myoepithelial cells. DNA analysis for flow cytometry was performed. The histogram presented a single peak in the G0-G1 area. The tumor was considered as being DNA diploid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201224     DOI: 10.1016/j.tripleo.2008.11.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  4 in total

1.  Nonsebaceous lymphadenoma of salivary glands: proposed development from intraparotid lymph nodes and risk of misdiagnosis.

Authors:  Christoph Weiler; Abbas Agaimy; Pamela Zengel; Johannes Zenk; Thomas Kirchner; Stephan Ihrler
Journal:  Virchows Arch       Date:  2012-04-04       Impact factor: 4.064

2.  Non-sebaceous lymphadenoma of the lacrimal gland: first report of a new localization.

Authors:  Mauro Pau; Luka Brcic; Raja R Seethala; Angelika K Klein-Theyer; Marton Magyar; Knut E Reinbacher; Michael Schweiger; Jürgen Wallner; Norbert Jakse
Journal:  Virchows Arch       Date:  2018-02-19       Impact factor: 4.064

3.  Malignant Transformation of Parotid Gland Non-sebaceous Lymphadenoma: Case Report and Review of Literature.

Authors:  Hakan Kara; Said Sönmez; Sidar Bağbudar; Mine Güllüoğlu; Bora Başaran
Journal:  Head Neck Pathol       Date:  2020-01-29

4.  Lymphadenoma of the salivary gland: Report of 10 cases.

Authors:  Guanglong Liu; Jie He; Chunye Zhang; Shuiting Fu; Yue He
Journal:  Oncol Lett       Date:  2014-01-24       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.